ICU Medical, Inc.ICUINASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank64
5Y CAGR-12.2%
Year-over-Year Change
Year-over-year SG&A expense growth
5Y CAGR
-12.2%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 1.99% |
| Q3 2025 | -4.15% |
| Q2 2025 | 1.37% |
| Q1 2025 | -1.02% |
| Q4 2024 | -2.37% |
| Q3 2024 | 1.98% |
| Q2 2024 | 1.20% |
| Q1 2024 | 1.97% |
| Q4 2023 | 4.04% |
| Q3 2023 | -1.51% |
| Q2 2023 | -1.10% |
| Q1 2023 | 6.74% |
| Q4 2022 | -6.85% |
| Q3 2022 | -3.34% |
| Q2 2022 | 3.61% |
| Q1 2022 | 88.09% |
| Q4 2021 | 8.88% |
| Q3 2021 | 1.21% |
| Q2 2021 | 2.11% |
| Q1 2021 | -1.58% |
| Q4 2020 | 3.81% |
| Q3 2020 | 5.37% |
| Q2 2020 | -7.00% |
| Q1 2020 | 2.34% |
| Q4 2019 | 7.25% |
| Q3 2019 | -2.87% |
| Q2 2019 | -6.62% |
| Q1 2019 | -8.69% |
| Q4 2018 | 1.89% |
| Q3 2018 | -6.55% |
| Q2 2018 | -3.98% |
| Q1 2018 | 12.78% |
| Q4 2017 | 0.42% |
| Q3 2017 | -9.74% |
| Q2 2017 | 31.16% |
| Q1 2017 | 187.13% |
| Q4 2016 | 1.06% |
| Q3 2016 | -0.57% |
| Q2 2016 | 2.35% |
| Q1 2016 | -2.42% |